ReactiveRobotics
Reactive Robotics will build robots for very early movement (VEM) rehabilitation after stroke and orthopaedic joint replacement with a patented, modular system that opens the new, €2.4 billion market of Intensive Care Unit (ICU) Rehabilitation Robotics. Stroke patients that underwent intensive VEM therapy could be transferred from the expensive ICU to less expensive standard care units at least one day earlier while showing significantly better clinical scores. Same is true for hip- or knee-joint replacement patients. However, so far there is no robotic device available that can automate the time consuming process of performing VEM, while seamlessly integrating itself into the workflow of an ICU.
Contract Awards
Consolidated award signal from sourced logistics events.
Links
Identity Trust
Computed from durable identifiers and the number of independent source systems attached to this entity.
Company News
No recent Spaceflight News articles matched this company.
Evidence
Profile Metadata
No records available.
Outgoing Relationships
No records available.
Incoming Relationships
ESA BIC lists ReactiveRobotics via ESA BIC incubatees and alumni.
All Contract Awards
No records available.